Bristol, PA, United States of America

Xinyi Song

USPTO Granted Patents = 5 


Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Jupiter, FL (US) (2013 - 2015)
  • Bristol, PA (US) (2016 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Xinyi Song: Innovator in Orexin Receptor Modulation

Introduction

Xinyi Song is a notable inventor based in Bristol, PA (US), recognized for his contributions to the field of pharmaceutical sciences. He holds five patents that focus on innovative compounds aimed at modulating orexin receptors, which play a crucial role in various medical conditions.

Latest Patents

His latest patents include "Substituted prolines/piperidines as orexin receptor antagonists." This invention is directed towards compounds that modulate the bioactivity of orexin receptors, specifically OXor OX, or both. The patents encompass pharmaceutical compositions and methods of treatment for various malconditions where modulation of an orexin receptor is medically indicated. These compounds can be utilized in treating a wide range of disorders, including eating disorders, obesity, alcoholism, drug addiction, sleep disorders, cognitive dysfunctions, and several psychiatric and neurological conditions.

Career Highlights

Xinyi Song has worked with prominent organizations such as Eolas Therapeutics, Inc. and The Scripps Research Institute. His work in these institutions has significantly contributed to the advancement of therapeutic strategies targeting orexin receptors.

Collaborations

Some of his notable coworkers include Theodore M Kamenecka and Rong Jiang, who have collaborated with him on various projects related to his patents and research.

Conclusion

Xinyi Song's innovative work in the modulation of orexin receptors has the potential to impact the treatment of numerous medical conditions. His contributions to pharmaceutical sciences highlight the importance of research and innovation in developing effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…